Literature DB >> 36087945

Should We Pretreat Before We Go Nuts? Antihistamines Modestly Reduce the Side Effects of Peanut Oral Immunotherapy.

Benjamin L Wright1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36087945      PMCID: PMC9503295          DOI: 10.1016/j.jaip.2022.06.015

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  9 in total

1.  AR101 Oral Immunotherapy for Peanut Allergy.

Authors:  Brian P Vickery; Andrea Vereda; Thomas B Casale; Kirsten Beyer; George du Toit; Jonathan O Hourihane; Stacie M Jones; Wayne G Shreffler; Annette Marcantonio; Rezi Zawadzki; Lawrence Sher; Warner W Carr; Stanley Fineman; Leon Greos; Rima Rachid; M Dolores Ibáñez; Stephen Tilles; Amal H Assa’ad; Caroline Nilsson; Ned Rupp; Michael J Welch; Gordon Sussman; Sharon Chinthrajah; Katharina Blumchen; Ellen Sher; Jonathan M Spergel; Frederick E Leickly; Stefan Zielen; Julie Wang; Georgiana M Sanders; Robert A Wood; Amarjit Cheema; Carsten Bindslev-Jensen; Stephanie Leonard; Rita Kachru; Douglas T Johnston; Frank C Hampel; Edwin H Kim; Aikaterini Anagnostou; Jacqueline A Pongracic; Moshe Ben-Shoshan; Hemant P Sharma; Allan Stillerman; Hugh H Windom; William H Yang; Antonella Muraro; José M Zubeldia; Vibha Sharma; Morna J Dorsey; Hey J Chong; Jason Ohayon; J Andrew Bird; Tara F Carr; Dareen Siri; Montserrat Fernández-Rivas; David K Jeong; David M Fleischer; Jay A Lieberman; Anthony E J Dubois; Marina Tsoumani; Christina E Ciaccio; Jay M Portnoy; Lyndon E Mansfield; Stephen B Fritz; Bruce J Lanser; Jonathan Matz; Hanneke N G Oude Elberink; Pooja Varshney; Stephen G Dilly; Daniel C Adelman; A Wesley Burks
Journal:  N Engl J Med       Date:  2018-11-18       Impact factor: 91.245

2.  Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety.

Authors:  Derek K Chu; Robert A Wood; Shannon French; Alessandro Fiocchi; Manel Jordana; Susan Waserman; Jan L Brożek; Holger J Schünemann
Journal:  Lancet       Date:  2019-04-25       Impact factor: 79.321

3.  Effect of sleep deprivation and exercise on reaction threshold in adults with peanut allergy: A randomized controlled study.

Authors:  Shelley Dua; Monica Ruiz-Garcia; Simon Bond; Stephen R Durham; Ian Kimber; Clare Mills; Graham Roberts; Isabel Skypala; James Wason; Pamela Ewan; Robert Boyle; Andrew Clark
Journal:  J Allergy Clin Immunol       Date:  2019-07-15       Impact factor: 10.793

4.  Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial.

Authors:  Paxton Loke; Francesca Orsini; Adriana C Lozinsky; Michael Gold; Michael D O'Sullivan; Patrick Quinn; Melanie Lloyd; Sarah E Ashley; Sigrid Pitkin; Christine Axelrad; Jessica R Metcalfe; Ee Lyn Su; Dean Tey; Marnie N Robinson; Katrina J Allen; Susan L Prescott; Audrey Dunn Galvin; Mimi L K Tang
Journal:  Lancet Child Adolesc Health       Date:  2022-02-04

5.  Risk Factors and Treatment Outcomes for Oral Immunotherapy-Induced Gastrointestinal Symptoms and Eosinophilic Responses (OITIGER).

Authors:  Michael R Goldberg; Liat Nachshon; Michael B Levy; Arnon Elizur; Yitzhak Katz
Journal:  J Allergy Clin Immunol Pract       Date:  2019-08-02

Review 6.  The use of biologics in food allergy.

Authors:  Alessandro Fiocchi; Brian P Vickery; Robert A Wood
Journal:  Clin Exp Allergy       Date:  2021-06-02       Impact factor: 5.018

7.  Gastrointestinal Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral Immunotherapy.

Authors:  Benjamin L Wright; Nielsen Q Fernandez-Becker; Neeraja Kambham; Natasha Purington; Shu Cao; Dana Tupa; Wenming Zhang; Sayantani B Sindher; Matthew A Rank; Hirohito Kita; David A Katzka; Kelly P Shim; Bryan J Bunning; Alfred D Doyle; Elizabeth A Jacobsen; Mindy Tsai; Scott D Boyd; Monali Manohar; R Sharon Chinthrajah
Journal:  Clin Gastroenterol Hepatol       Date:  2020-05-17       Impact factor: 13.576

8.  Effect of ketotifen premedication on adverse reactions during peanut oral immunotherapy.

Authors:  Amanda Jagdis; Noam Berlin; Carly Barron; Mohana Giruparajah; Nathan Leader; Sean Maclachlan; Gordon L Sussman
Journal:  Allergy Asthma Clin Immunol       Date:  2014-07-09       Impact factor: 3.406

9.  New efficacy of LTRAs (montelukast sodium): it possibly prevents food-induced abdominal symptoms during oral immunotherapy.

Authors:  Masaya Takahashi; Shoichiro Taniuchi; Kazuhiko Soejima; Kyoko Sudo; Yasuko Hatano; Kazunari Kaneko
Journal:  Allergy Asthma Clin Immunol       Date:  2014-01-17       Impact factor: 3.406

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.